219 related articles for article (PubMed ID: 37129716)
1. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).
Serrano C; Álvarez R; Carrasco JA; Marquina G; Martínez-García J; Martínez-Marín V; Sala MÁ; Sebio A; Sevilla I; Martín-Broto J
Clin Transl Oncol; 2023 Sep; 25(9):2707-2717. PubMed ID: 37129716
[TBL] [Abstract][Full Text] [Related]
2. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016).
Poveda A; Martinez V; Serrano C; Sevilla I; Lecumberri MJ; de Beveridge RD; Estival A; Vicente D; Rubió J; Martin-Broto J
Clin Transl Oncol; 2016 Dec; 18(12):1221-1228. PubMed ID: 27896638
[TBL] [Abstract][Full Text] [Related]
3. 2023 GEIS Guidelines for gastrointestinal stromal tumors.
Serrano C; Martín-Broto J; Asencio-Pascual JM; López-Guerrero JA; Rubió-Casadevall J; Bagué S; García-Del-Muro X; Fernández-Hernández JÁ; Herrero L; López-Pousa A; Poveda A; Martínez-Marín V
Ther Adv Med Oncol; 2023; 15():17588359231192388. PubMed ID: 37655207
[TBL] [Abstract][Full Text] [Related]
4. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
Zalcberg JR
Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
[TBL] [Abstract][Full Text] [Related]
5. New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors.
Serrano C; Bauer S
Curr Oncol Rep; 2022 Feb; 24(2):151-159. PubMed ID: 35061196
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for the treatment of gastrointestinal stromal tumors.
Pilco-Janeta DF; García-Valverde A; Gomez-Peregrina D; Serrano C
Expert Opin Emerg Drugs; 2021 Mar; 26(1):53-62. PubMed ID: 33645383
[TBL] [Abstract][Full Text] [Related]
7. SEOM guidelines for gastrointestinal stromal sarcomas (GIST).
Poveda A; Rivera F; Martín J; ;
Clin Transl Oncol; 2012 Jul; 14(7):536-40. PubMed ID: 22721799
[TBL] [Abstract][Full Text] [Related]
8. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal stromal tumors (GIST)].
Jaros D; Bozic B; Sebesta C
Wien Med Wochenschr; 2023 Jun; 173(9-10):201-205. PubMed ID: 36155864
[TBL] [Abstract][Full Text] [Related]
10. GEIS 2013 guidelines for gastrointestinal sarcomas (GIST).
Poveda A; del Muro XG; López-Guerrero JA; Martínez V; Romero I; Valverde C; Cubedo R; Martín-Broto J
Cancer Chemother Pharmacol; 2014 Nov; 74(5):883-98. PubMed ID: 25193432
[TBL] [Abstract][Full Text] [Related]
11. GEIS guidelines for gastrointestinal sarcomas (GIST).
Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J;
Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
Mohammadi M; Gelderblom H
Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
[No Abstract] [Full Text] [Related]
13. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
George S; Jones RL; Bauer S; Kang YK; Schöffski P; Eskens F; Mir O; Cassier PA; Serrano C; Tap WD; Trent J; Rutkowski P; Patel S; Chawla SP; Meiri E; Gordon M; Zhou T; Roche M; Heinrich MC; von Mehren M
Oncologist; 2021 Apr; 26(4):e639-e649. PubMed ID: 33453089
[TBL] [Abstract][Full Text] [Related]
14. Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward.
Lostes-Bardaji MJ; García-Illescas D; Valverde C; Serrano C
Ther Adv Med Oncol; 2021; 13():1758835920986498. PubMed ID: 33473249
[TBL] [Abstract][Full Text] [Related]
15. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.
Koo DH; Ryu MH; Kim KM; Yang HK; Sawaki A; Hirota S; Zheng J; Zhang B; Tzen CY; Yeh CN; Nishida T; Shen L; Chen LT; Kang YK
Cancer Res Treat; 2016 Oct; 48(4):1155-1166. PubMed ID: 27384163
[TBL] [Abstract][Full Text] [Related]
16. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates.
Farag S; Smith MJ; Fotiadis N; Constantinidou A; Jones RL
Curr Treat Options Oncol; 2020 May; 21(7):55. PubMed ID: 32462367
[TBL] [Abstract][Full Text] [Related]
17. The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.
Schaefer IM; DeMatteo RP; Serrano C
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-15. PubMed ID: 35522913
[TBL] [Abstract][Full Text] [Related]
18. Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis.
Gupta A; Singh J; García-Valverde A; Serrano C; Flynn DL; Smith BD
Mol Cancer Ther; 2021 Jul; 20(7):1234-1245. PubMed ID: 33947686
[TBL] [Abstract][Full Text] [Related]
19. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
Blay JY; Bonvalot S; Casali P; Choi H; Debiec-Richter M; Dei Tos AP; Emile JF; Gronchi A; Hogendoorn PC; Joensuu H; Le Cesne A; McClure J; Maurel J; Nupponen N; Ray-Coquard I; Reichardt P; Sciot R; Stroobants S; van Glabbeke M; van Oosterom A; Demetri GD;
Ann Oncol; 2005 Apr; 16(4):566-78. PubMed ID: 15781488
[TBL] [Abstract][Full Text] [Related]
20. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib.
Di Vito A; Ravegnini G; Gorini F; Aasen T; Serrano C; Benuzzi E; Coschina E; Monesmith S; Morroni F; Angelini S; Hrelia P
Pharmacol Ther; 2023 Aug; 248():108475. PubMed ID: 37302758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]